Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press198310.17650/1726-9776-2025-21-3-148-156REVIEWSОБЗОРЫReview ArticleRenal cell carcinoma in patients with nephrolithiasis: systematic reviewТочки соприкосновения почечно-клеточного рака и нефролитиаза: систематический обзорhttps://orcid.org/0000-0003-2767-7153PopovS. V.ПоповС. В.
Russian Federation
tatianalelyavina@mail.ruhttps://orcid.org/0000-0001-9935-0243GuseynovR. G.ГусейновР. Г.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0000-0003-4780-8720Isakova-SivakI. N.Исакова-СивакИ. Н.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0000-0003-4064-5033SivakK. V.СивакК. В.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0000-0002-6664-2861SkryabinO. N.СкрябинО. Н.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0000-0003-2841-0370GorbachevaI. A.ГорбачеваИ. А.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0000-0003-4331-028XBunenkovN. S.БуненковН. С.
Russian Federation
bunenkov2006@gmail.comhttps://orcid.org/0000-0001-6294-6182MalyshevE. A.МалышевЕ. А.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0009-0004-6436-3860BeshtoevA. K.БештоевА. Х.
Russian Federation
info@lucaclinic.ruhttps://orcid.org/0000-0001-6796-4064LelyavinaT. A.ЛелявинаT. А.
Russian Federation
tatianalelyavina@mail.ruSt. Luka’s Clinical HospitalСПб ГБУЗ Клиническая больница Святителя ЛукиSaint Petersburg Medical and Social InstituteЧОУ ВО «Санкт-Петербургский медико-социальный институт»Saint Petersburg State UniversityФГБОУ ВО «Санкт-Петербургский государственный университет»A.A. Smorodintsev Research Institute of Influenza, Ministry of Health of RussiaФГБУ «Научно-исследовательский институт гриппа им. А. А. Смородинцева» Минздрава РоссииV.A. Almazov National Medical Research Centre, Ministry of Health of RussiaФГБУ «Национальный медицинский исследовательский центр им. В. А. Алмазова» Минздрава России181220252131481562010202512112025Copyright ©; 2025, Popov S.V., Guseynov R.G., Isakova-Sivak I.N., Sivak K.V., Skryabin O.N., Gorbacheva I.A., Bunenkov N.S., Malyshev E.A., Beshtoev A.K., Lelyavina T.A.Copyright ©; 2025, Попов С.В., Гусейнов Р.Г., Исакова-Сивак И.Н., Сивак К.В., Скрябин О.Н., Горбачева И.А., Буненков Н.С., Малышев Е.А., Бештоев А.Х., Лелявина T.А.2025Popov S.V., Guseynov R.G., Isakova-Sivak I.N., Sivak K.V., Skryabin O.N., Gorbacheva I.A., Bunenkov N.S., Malyshev E.A., Beshtoev A.K., Lelyavina T.A.Попов С.В., Гусейнов Р.Г., Исакова-Сивак И.Н., Сивак К.В., Скрябин О.Н., Горбачева И.А., Буненков Н.С., Малышев Е.А., Бештоев А.Х., Лелявина T.А.https://creativecommons.org/licenses/by/4.0https://oncourology.eco-vector.com/oncur/article/view/1983

This review examines literature data on the possible relationship between development of kidney cancer and long-term nephrolithiasis. Results of research on the epidemiology of the diseases in question are presented, key take-aways and conclusions of the specialists who study this problem are reflected, current state of the issues of kidney stones-associated carcinogenesis of malignant kidney lesions is shown.

В предлагаемом обзоре рассмотрены данные литературы, касающиеся возможной взаимосвязи между развитием рака почки и многолетней мочекаменной болезнью. Представлены результаты исследований эпидемиологии рассматриваемых заболеваний, отражены выводы и заключения специалистов, изучавших эту проблему, показано современное состояние вопросов канцерогенеза злокачественных поражений почки, ассоциированного с мочекаменной болезнью.

kidney cancerurolithiasiskidney stones-associated carcinogenesis of kidney cancerрак почкимочекаменная болезньканцерогенез рака почки, ассоциированный с мочекаменной болезньюКомитет по здравоохранению Санкт-ПетербургаSt. Petersburg Health CommitteeAbufaraj M., Xu T., Cao C. et al. Prevalence and trends in kidney stone among adults in the USA: analyses of National Health and Nutrition Examination Survey 2007–2018 data. Eur Urol Focus 2021;7(6):1468–75. DOI: 10.1016/j.euf.2020.08.011Gillams K., Juliebø-Jones P., Juliebø S.Ø., Somani B.K. Gender differences in kidney stone disease (KSD): findings from a systematic review. Curr Urol Rep 2021;22(10):50. DOI: 10.1007/s11934-021-01066-6Zhu C., Wang D.Q., Zi H. et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res 2021;8(1):64. DOI: 10.1186/s40779-021-00359-8Lang J., Narendrula A., El-Zawahry A. et al. Global trends in incidence and burden of urolithiasis from 1990 to 2019: an analysis of Global Burden of Disease Study data. Eur Urol Open Sci 2022;35:37–46. DOI: 10.1016/j.euros.2021.10.008Li S., Huang X., Liu J. et al. Trends in the incidence and DALYs of urolithiasis from 1990 to 2019: results from the Global Burden of Disease Study 2019. Front Public Health 2022;10:825541. DOI: 10.3389/fpubh.2022.825541Zhang L., Zhang X., Pu Y. et al. Global, regional, and national burden of urolithiasis from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Clin Epidemiol 2022;14:971–83. DOI: 10.2147/CLEP.S370591Qian X., Wan J., Xu J. et al. Epidemiological trends of urolithiasis at the global, regional, and national levels: a population-based study. Int J Clin Pract 2022;2022:6807203. DOI: 10.1155/2022/6807203Borumandnia N., Fattahi P., Talebi A. et al. Longitudinal trend of urolithiasis incidence rates among world countries during past decades. BMC Urol 2023;23(1):166. DOI: 10.1186/s12894-023-01336-0Li J., Zhao Y., Xiong Z., Yang G. Global, regional, and national incidence and disability-adjusted life-years for urolithiasis in 195 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. J Clin Med 2023;12(3):1048. DOI: 10.3390/jcm12031048Sorokin I., Mamoulakis C., Miyazawa K. et al. Epidemiology of stone disease across the world. World J Urol 2017;35(9):1301–20. DOI: 10.1007/s00345-017-2008-6Zubkov I.V., Biteev V.H., Korotaev P.N. et al. Epidemiology of urolithiasis and results of a pilot study of the use of fibrocalicolithotripsy. Russkiy meditsinskiy zhurnal = Russian Medical Journal 2021;8:7–10. (In Russ.).Зубков И.В., Битеев В.Х., Коротаев П.Н. и др. Эпидемиология мочекаменной болезни и результаты пилотного исследования использования фиброкаликолитотрипсии. Русский медицинский журнал 2021;8:7–10.Moe O.W. Kidney stones: pathophysiology and medical management. Lancet 367(9507):333–44. DOI: 10.1016/S0140-6736(06)68071-9Saadeh S.A. Pediatric nephrolithiasis: risk factors, evaluation, and prevention. Pediatr Ann 49(6):e262–7. DOI: 10.3928/19382359-20200518-01Chuang T.F., Hung H.C., Li S.F. et al. Risk of chronic kidney disease in patients with kidney stones-a nationwide cohort study BMC Nephrol 2020;21(1):292. DOI: 10.1186/s12882-020-01950-2Ando R., Nagaya T., Suzuki S. et al. Independent and interactive effects of kidney stone formation and conventional risk factors for chronic kidney disease: a follow-up study of Japanese men. Int Urol Nephrol 2021;53(6):1081–7. DOI: 10.1007/s11255-021-02803-zBrain E., Geraghty R.M., Cook P. et al. Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years. World J Urol 2021;39(8):3095–101. DOI: 10.1007/s00345-020-03564-7Chung S.D., Chen Y.K., Lin H.C. Increased risk of diabetes in patients with urinary calculi: a 5-year followup study. J Urol 2011;186(5):1888–93. DOI: 10.1016/j.juro.2011.07.011Canda A.E., Isgoren A.E. Re: Increased risk of diabetes in patients with urinary calculi: a 5-year followup study: S.-D. Chung, Y.-K. Chen and H.-C. Lin. J Urol 2011;186:1888–1893. J Urol 2012;187(6):2279–80. DOI: 10.1016/j.juro.2012.01.132Kittanamongkolchai W., Mara K.C., Mehta R.A. et al. Risk of hypertension among first-time symptomatic kidney stone formers. Clin J Am Soc Nephrol 2017;12(3):476–82. DOI: 10.2215/CJN.06600616Geraghty R.M., Cook P., Roderick P., Somani B. Risk of metabolic syndrome in kidney stone formers: a comparative cohort study with a median follow-up of 19 years. J Clin Med 2021;10(5):978. DOI: 10.3390/jcm10050978Order of 26.07.2024 No. 374n of the Ministry of Labor and Social Protection of the Russian Federation “On approval of classifications and criteria used in the implementation of medical and social expertise.” Available at: http://publication.pravo.gov.ru/document/0001202408260026Приказ от 26.07.2024 № 374н Министерства труда и социальной защиты РФ «Об утверждении классификаций и критериев, используемых при осуществлении медико-социальной экспертизы». Доступно по: http://publication.pravo.gov.ru/document/0001202408260026Knoll T. Epidemiology, pathogenesis and pathophysiology of urolithiasis. Eur Urol Suppl 2010;9:802–6. DOI: 10.1016/j.eursup.2010.11.006Türk C., Knoll T., Petrik A. EAU Guidelines on urolithiasis. European Association of Urology, 2011. 104 p.Ziemba J.B., Matlaga B.R. Epidemiology and economics of nephrolithiasis. Investig Clin Urol 2017;58(5):299–306. DOI: 10.4111/icu.2017.58.5.299Shin S., Srivastava A., Alli N.A., Bandyopadhyay B.C. Confounding risk factors and preventative measures driving nephrolithiasis global makeup. World J Nephrol 2018;7(7):129–42. DOI: 10.5527/wjn.v7.i7.129Sorokin I., Pearle M.S. Medical therapy for nephrolithiasis: state of the art. Asian J Urol 2018;5(4):243–55. DOI: 10.1016/j.ajur.2018.08.005Roberson D., Sperling C., Shah A., Ziemba J. Economic considerations in the management of nephrolithiasis. Curr Urol Rep 2020;21(5):18. DOI: 10.1007/s11934-020-00971-6Thongprayoon C., Krambeck A.E., Rule A.D. Determining the true burden of kidney stone disease. Nat Rev Nephrol 2020;16(12): 736–46. DOI: 10.1038/s41581-020-0320-7Wang C., Du R., Jin J. et al. Use of whole-exome sequencing to identify a novel ADCY10 mutation in a patient with nephrolithiasis. Am J Transl Res 2020;12(8):4576–81. PMID: 32913531.Alathel A., Alfraidi O., Alsayyari A.S.A. et al. Exploring the incidence and characteristics of urolithiasis in the central region of Saudi Arabia: insights from a prominent medical center. Urol Ann 2024;16(3):233–40. DOI: 10.4103/ua.ua_1_24Alyaev Yu.G., Pshikhachev A.M., Shpot E.V. et al. Kidney tumor and urolithiasis: is there a relationship? Urologiya = Urology 2016;3:104–6. (In Russ.).Аляев Ю.Г., Пшихачев А.М., Шпоть Е.В. и др. Опухоль почки и мочекаменная болезнь: существует ли взаимосвязь? Урология 2016;3:104–6.Bai X., Yi M., Dong B. et al. The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017. Exp Hematol Oncol 2020;9:27. DOI: 10.1186/s40164-020-00181-3Cai Q., Chen Y., Qi X. et al. Temporal trends of kidney cancer incidence and mortality from 1990 to 2016 and projections to 2030. Transl Androl Urol 2020;9(2):166–81. DOI: 10.21037/tau.2020.02.23Du Z., Chen W., Xia Q. et al. Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study. Biomark Res 2020;8:16. DOI: 10.1186/s40364-020-00195-3Safiri S., Kolahi A.A., Mansournia M.A. et al. The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017. Sci Rep 2020;10(1):13862. DOI: 10.1038/s41598-020-70840-2Zi H., He S.H., Leng X.Y. et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Mil Med Res 2021;8(1):60. DOI: 10.1186/s40779-021-00354-zHuang J., Leung D.K., Chan E.O. et al. A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur Urol Focus 2022;8(1):200–9. DOI: 10.1016/j.euf.2020.12.020Jani C., Abdallah N., Mouchati C. et al. Trends of kidney cancer burden from 1990 to 2019 in European Union 15+ countries and World Health Organization regions. Sci Rep 2022;12(1):22368. DOI: 10.1038/s41598-022-25485-8Safiri S., Nejadghaderi S.A., Abdollahi M. et al. Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990–2019. Cancer Med 2022;11(13):2662–78. DOI: 10.1002/cam4.4647Zhan Y., Pan C., Zhao Y. et al. Systematic analysis of the global, regional and national burden of kidney cancer from 1990 to 2017: results from the Global Burden of Disease Study 2017. Eur Urol Focus 2022;8(1):302–19. DOI: 10.1016/j.euf.2021.01.006Tian Y.Q., Yang J.C., Hu J.J. et al. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: systematic analysis for the Global Burden of Disease Study 2019. Front Public Health 2023;11:1119374. DOI: 10.3389/fpubh.2023.1119374Xu Q., Zhang T., Xia T. et al. Epidemiological trends of kidney cancer along with attributable risk factors in China from 1990 to 2019 and its projections until 2030: an analysis of the Global Burden of Disease Study 2019. Clin Epidemiol 2023;15:421–33. DOI: 10.2147/CLEP.S400646Huang Q., Yang J., Liu G.X. et al. Changes in disease burden and global inequalities in bladder, kidney and prostate cancers from 1990 to 2019: a comparative analysis based on the global burden of disease study 2019. BMC Public Health 2024;24(1):891. DOI: 10.1186/s12889-024-18353-9State of oncological care in Russia in 2023. Eds.: А.D. Kaprin, V.V. Starinskiy, A.O. Shachzadova. Moscow: MNIOI im. P.A. Gertsena – filial FGBU “NMITS radiologii” Minzdrava Rossii, 2024. 262 p. (In Russ.).Состояние онкологической помощи населению России в 2023 го-ду. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2024. 262 с.Popov S.V., Guseinov R.G., Orlov I.N. et al. Prevalence of malignant neoplasms of the kidney in St. Petersburg and various regions of Russia in 2016–2021. Onkourologiya = Cancer Urology 2023;19(3):163–74. (In Russ.). DOI: 10.17650/1726-9776-2023-19-3-163-174Попов С.В., Гусейнов Р.Г., Орлов И.Н. и др. Распространенность злокачественных новообразований почки в г. Санкт-Петербурге и различных регионах России в 2016–2021 г. Онкоурология 2023;19(3):163–74. DOI: 10.17650/1726-9776-2023-19-3-163-174Eck H. Renal calculus, carcinoma of the renal pelvis and expert testimony. Bruns Beitr Klin Chir 1960;201:31–6. PMID: 13725585.Kato T., Chabata T., Kazuta M. A case of squamous cell carcinoma of the renal pelvis associated with staghorn stone. Hinyokika Kiyo 1966;12(1):43–6. PMID: 5950233Solari J.J. Tumores del riñón y litiasis renal. Dos casos. Rev Argent Urol Nefrol 1966;35(1):11–3. PMID: 5988983. (Spanish).Jalundhwala J.M., Shah R.C. Renal cell carcinoma associated with renal calculus. J Indian Med Assoc 1967;49(5):236–7. PMID: 5587619Reddy D.B., Rao N., Venkateswararao K., Venkateswararao N. Squamous cell carcinoma of the renal pelvis. Associated with the calculus of the kidney. (A study of four cases with review of literature). Indian J Cancer 1969;6(1):27–33. PMID: 5795300Murdzhev A. Association of nephrolithiasis and renal cancer. Urol Nefrol (Mosk) 1970;35(3):57–8. (In Russ.). PMID: 5448449Czerniawski J., Musierowicz A., Nowiński A., Chilimoniuk M. A case of clear-cell renal carcinoma coexisting with renolithiasis diagnosed prior to surgery. Polish J Surg 1976;48:277–9. (In Polish). PMID: 1250791Jemni M., Mosbah A., Allegue M. et al. Renal lithiasis and urothelial tumor. Ann Urol (Paris) 1987;21(5):341–5. (in French). PMID: 3426161Chow W.H., Lindblad P., Gridley G. et al. Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 1997;89(19):1453–7. DOI: 10.1093/jnci/89.19.1453Sivaramakrishna B., Aron M., Ansari M.S. et al. Squamous cell carcinoma of the renal pelvis manifesting after percutaneous nephrolithotomy for long standing calculus. Int Urol Nephrol 2004;36(2):149–51. DOI: 10.1023/b:urol.0000034672.68658.faKatz R., Gofrit O.N., Golijanin D. et al. Urothelial cancer of the renal pelvis in percutaneous nephrolithotomy patients. Urol Int 2005;75(1):17–20. DOI: 10.1159/000085921Paonessa J., Beck H., Cook S. Squamous cell carcinoma of the renal pelvis associated with kidney stones: a case report. Med Oncol 2011;28:S392–4. DOI: 10.1007/s12032-010-9704-zJongyotha K., Sriphrapradang C. Squamous cell carcinoma of the renal pelvis as a result of long-standing staghorn calculi. Case Rep Oncol 2015;8(3):399–404. DOI: 10.1159/000440764Kondisetty S., Borkar P.V., Thomas A. Nephrectomy for infected stag horn calculus confounded by the presence of squamous cell carcinoma. BMJ Case Rep 2017;2017:bcr2017220230. DOI: 10.1136/bcr-2017-220230Liu X.H., Zou Q.M., Cao J.D., Wang Z.C. Primary squamous cell carcinoma with sarcomatoid differentiation of the kidney associated with ureteral stone obstruction: A case report. World J Clin Cases 2022;10(32):11942–8. DOI: 10.12998/wjcc.v10.i32.11942Hosseinzadeh M., Mohammadzadeh S. Primary pure squamous cell carcinoma of kidney associated with multiple stag horn stones. Int Med Case Rep J 2020;13:261–3. DOI: 10.2147/IMCRJ.S261022Chung S.D., Liu S.P., Lin H.C. A population-based study on the association between urinary calculi and kidney cancer. Can Urol Assoc J 2013;7(11–12):E716–21. DOI: 10.5489/cuaj.366Sun L.M., Lin C.L., Chang Y.J. et al. Urinary tract stone raises subsequent risk for urinary tract cancer: a population-based cohort study. BJU Int 2013;112(8):1150–5. DOI: 10.1111/bju.12402Shih C.J., Chen Y.T., Ou S.M. et al. Urinary calculi and risk of cancer: a nationwide population-based study. Medicine (Baltimore) 2014:93(29):e342. DOI: 10.1097/MD.0000000000000342Lin C.L., Huang W.T., Fan W.C. et al. Associations between interventions for urolithiasis and urinary tract cancer among patients in Taiwan: The effect of early intervention. Medicine (Baltimore) 2016;95(49):e5594. DOI: 10.1097/MD.0000000000005594Van de Pol J.A.A., van den Brandt P.A., Schouten L.J. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study. Br J Cancer 2019;120(3):368–74. DOI: 10.1038/s41416-018-0356-7Cheungpasitporn W., Thongprayoon C., O’Corragain O.A. et al. The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM 2015;108(3):205–12. DOI: 10.1093/qjmed/hcu195Grashchenko I.S., Drobot N.T., Klimov A.V. et al. Tumor of the renal pelvis accompanying coral nephrolithiasis. Onkologicheskiy zhurnal: luchevaya diagnostika, luchevaya terapiya = Journal of Oncology: Diagnostic Radiology and Radiotherapy 2024;7(2):98–104. (In Russ.). DOI: 10.37174/2587-7593-2024-7-2-98-104Гращенко И.С., Дробот Н.Ц., Климов А.В. и др. Опухоль почечной лоханки на фоне коралловидного нефролитиаза. Онкологический журнал: лучевая диагностика, лучевая терапия 2024;7(2):98–104. DOI: 10.37174/2587-7593-2024-7-2-98-104Parker A.S., Cerhan J.R., Lynch C.F. et al. History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol 2004;159(1):42–8. DOI: 10.1093/aje/kwh014Jiang P., Wang C., Chen S. et al. Primary renal squamous cell carcinoma mimicking the renal cyst: a case report and review of the recent literature. BMC Urol 2015;15:69. DOI: 10.1186/s12894-015-0064-zKivlin D., Tong C., Friedlander J. et al. Sarcomatoid squamous cell carcinoma of the renal pelvis masquerading as emphysematous pyelonephritis with staghorn calculus. J Endourol Case Rep 2016;2(1):87–9. DOI: 10.1089/cren.2016.0047Hassan M., Qureshi A. Incidental squamous cell carcinoma of the renal pelvis in a non functioning kidney that wwas missed on two non-contrast ct-scans. J Ayub Med Coll Abbottabad 2017;29(3):489–92. PMID: 29076690.Alves R.A.D.C., Barroso F.M.D.S., de Andrade G.F.Jr. et al. Surgical treatment of kidney tumor on a patient with second case of staghorn calculus and associated renal hydronephrosis: case report. AME Case Rep 2019;3:19. DOI: 10.21037/acr.2019.05.08Sogaard K.K., Veres K., Norgaard M. et al. Pyelonephritis in persons after age 50 as a clinical marker of urogenital cancer. Clin Microbiol Infect 2019;25(1):87–91. DOI: 10.1016/j.cmi.2018.04.003Gupta S., Singh Kanwar S. The influence of dysbiosis on kidney stones that risk up renal cell carcinoma (RCC). Semin Cancer Biol 2021;70:134–8. DOI: 10.1016/j.semcancer.2020.06.011Panasenko O.M., Sokolov A.V. Reactive forms of halogens, halogenating stress, its biomarkers. Role in the development of human diseases. Bioradikaly i antioksidanty = Bioradicals and Antioxidants 2018;5(3):53–6.Панасенко О.М., Соколов А.В. Активные формы галогенов, галогенирующий стресс, его биомаркеры. Роль в развитии заболеваний человека. Биорадикалы и антиоксиданты 2018;5(3):53–6.Kroncke K.D. Nitrosative stress and transcription. Biol Chem 2003;384(10–11):1365–77. DOI: 10.1515/BC.2003.153Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 2003;111(6):769–78. DOI: 10.1172/JCI18174Descamps-Latscha B., Witko-Sarsat V., Nguyen-Khoa T. et al. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2005;45(1):39–47. DOI: 10.1053/j.ajkd.2004.09.011Valko M., Leibfritz D., Moncol J. et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39(1):44–84. DOI: 10.1016/j.biocel.2006.07.001Kisic B., Miric D., Dragojevic I. et al. Role of myeloperoxidase in patients with chronic kidney disease. Oxid Med Cell Longev 2016;2016:1069743. DOI: 10.1155/2016/1069743Aratani Y. Myeloperoxidase: its role for host defense, infammation, and neutrophil function. Arch Biochem Biophys 2018;640:47–52. DOI: 10.1016/j.abb.2018.01.004Pravalika K., Sarmah D., Kaur H. et al. Myeloperoxidase and neurological disorder: a crosstalk. ACS Chem Neurosci 2018;9(3):421–30. DOI: 10.1021/acschemneuro.7b00462Ndrepepa G. Myeloperoxidase – a bridge linking infammation and oxidative stress with cardiovascular disease. Clin Chim Acta 2019;493:36–51. DOI: 10.1016/j.cca.2019.02.022Davies M.J., Hawkins C.L. The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease. Antioxid Redox Signal 2020;32(13):957–81. DOI: 10.1089/ars.2020.8030Ulfig A., Leichert L.I. The effects of neutrophil-generated hypochlorous acid and other hypohalous acids on host and pathogens. Cell Mol Life Sci 2021;78(2):385–414. DOI: 10.1007/s00018-020-03591-yWarli S.M., Mantiri B.J., Sihombing B. et al. Nephrolithiasis-associated renal cell carcinoma in patients who underwent nephrectomy: a single-center experience. World J Oncol 2023;14(1):94–100. DOI: 10.14740/wjon1560Scelo G., Larose T.L. Epidemiology and risk factors for kidney cancer. J Clin Oncol 2018;36(36):JCO2018791905. DOI: 10.1200/JCO.2018.79.1905Raikhman Ya.G. Theoretical foundations of cancer prevention. Moscow, 2009. 350 p.Райхман Я.Г. Теоретические основы профилактики рака. М., 2009. 350 с.Lipworth L., Tarone R.E., Lund L., McLaughlin J.K. Epidemiologic characteristics and risk factors for renal cell cancer. Clin Epidemiol 2009;1:33–43. DOI: 10.2147/clep.s4759Macleod L.C., Hotaling J.M., Wright J.L. et al. Risk factors for renal cell carcinoma in the VITAL study. J Urol 2013;190(5): 1657–61. DOI: 10.1016/j.juro.2013.04.130Capitanio U., Bensalah K., Bex A. et al. Epidemiology of renal cell. Eur Urol 2019;75(1):74–84. DOI: 10.1016/j.eururo.2018.08.036Minami T., Inoue M., Sawada N. et al. Alcohol consumption, tobacco smoking, and subsequent risk of renal cell carcinoma: The JPHC study. Cancer Sci 2021;112(12):5068–77. DOI: 10.1111/cas.15129Bukavina L., Bensalah K., Bray F. et al. Epidemiology of renal cell carcinoma: 2022 Update. Eur Urol 2022;82(5):529–42. DOI: 10.1016/j.eururo.2022.08.019Campi R., Rebez G., Klatte T. et al. Effect of smoking, hypertension and lifestyle factors on kidney cancer – perspectives for prevention and screening programmes. Nat Rev Urol 2023;20(11):669–81. DOI: 10.1038/s41585-023-00781-8Pal D.K., Maurya A.K., Jana D. Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: a retrospective single-center study. Indian J Cancer 2018;55(3):297–300. DOI: 10.4103/ijc.IJC_636_17Lughezzani G., Paciotti M., Fasulo V. et al. Gender-specific risk factors for renal cell carcinoma: a systematic review. Curr Opin Urol 2019;29(3):272–8. DOI: 10.1097/MOU.0000000000000603Yanus G.A., Ievleva A.G., Suspitsyn E.N. et al. Hereditary predisposition to malignant tumors of the kidney: tumor syndromes, multisystem diseases and nephropathy. Sechenovskiy vestnik = Sechenov Bulletin 2023;14(2):5–20. DOI: 10.47093/2218-7332.2023.14.2.5-20Янус Г.А., Иевлева А.Г., Суспицын Е.Н. и др. Наследственная предрасположенность к злокачественным опухолям почки: опухолевые синдромы, мультисистемные заболевания и нефропатии. Cеченовский вестник 2023;14(2):5–20. DOI: 10.47093/2218-7332.2023.14.2.5-20Graff R.E., Sanchez A., Tobias D.K. et al. Type 2 diabetes in relation to the risk of renal cell carcinoma among men and women in two large prospective cohort studies. Diabetes Care 2018;41(7):1432–7. DOI: 10.2337/dc17-2518Tahbaz R., Schmid M., Merseburger A.S. Prevention of kidney cancer incidence and recurrence: lifestyle, medication and nutrition. Curr Opin Urol 2018;28(1):62–79. DOI: 10.1097/MOU.0000000000000454Turco F., Tucci M., Di Stefano R.F. et al. Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. Endocr Relat Cancer 2021;28(7):R207–R216. DOI: 10.1530/ERC-20-0457Lee S.W., Kim H.J., Kazmi S.Z. et al. Familial risk of renal cell cancer and interaction with obesity and hyperglycemia: a population-based study. J Urol 2022;208(2):251–8. DOI: 10.1097/JU.0000000000002506Luo Q., Hofmann J.N., Pfeiffer R.M. et al. Impact of overweight and obesity on US renal cell carcinoma incidence trends (1995–2018). Int J Cancer 2023;153(1):64–72. DOI: 10.1002/ijc.34516Alekseeva G.N. Kidney cancer in the region of Siberia and the Far East. Epidemiological features, risk factors, early diagnosis and treatment effectiveness. Dis. ... doctor of medical sciences. Tomsk, 2019. 341 p.Алексеева Г.Н. Рак почки в регионе Сибири и Дальнего Востока. Эпидемиологические особенности, факторы риска, ранняя диагностика и эффективность лечения. Дис. … д-ра мед. наук. Томск, 2019. 341 с.Satwikananda H., Wiratama M.A., Putri K.T.C., Soebadi D.M. Renal cell carcinoma in a patient with staghorn stones: a case report. Int J Surg Case Rep 2023;110:108678. DOI: 10.1016/j.ijscr.2023.108678Dzitiev V.K., Sorokin N.I., Sinitsyn V.E. et al. Coral-shaped nephrolithiasis and squamous cell carcinoma of the renal pelvis: a clinical observation and a review of the literature. Vestnik urologii = Bulletin of Urology 2023;11(2):171–80. DOI: 10.21886/2308-6424-2023-11-2-171-180Дзитиев В.К., Сорокин Н.И., Синицын В.Е. и др. Коралловидный нефролитиаз и плоскоклеточный рак лоханки: клиническое наблюдение и обзор литературных данных. Вестник урологии 2023;11(2):171–80. DOI: 10.21886/2308-6424-2023-11-2-171-180Xiao J., Lei J., He L., Yin G. Renal calculus complicated with squamous cell carcinoma of renal pelvis: report of two cases. Can Urol Assoc J 2015;9(5–6):E310–2. DOI: 10.5489/cuaj.2441Tsuboi I., Maruyama Y., Araki M. et al. Advanced renal pelvic carcinoma revealed after treatment of a staghorn calculus by endoscopic combined intrarenal surgery. Case Rep Urol 2020;2020:9703479. DOI: 10.1155/2020/9703479